160 related articles for article (PubMed ID: 7749854)
1. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL.
Bergmark C; Wu R; de Faire U; Lefvert AK; Swedenborg J
Arterioscler Thromb Vasc Biol; 1995 Apr; 15(4):441-5. PubMed ID: 7749854
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease.
Lehtimäki T; Lehtinen S; Solakivi T; Nikkilä M; Jaakkola O; Jokela H; Ylä-Herttuala S; Luoma JS; Koivula T; Nikkari T
Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):23-7. PubMed ID: 9888862
[TBL] [Abstract][Full Text] [Related]
3. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.
Maggi E; Marchesi E; Ravetta V; Martignoni A; Finardi G; Bellomo G
J Hypertens; 1995 Jan; 13(1):129-38. PubMed ID: 7759843
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against oxidatively modified LDL do not constitute a risk factor for stroke: a nested case-control study.
Ahmed E; Trifunovic J; Stegmayr B; Hallmans G; Lefvert AK
Stroke; 1999 Dec; 30(12):2541-6. PubMed ID: 10582975
[TBL] [Abstract][Full Text] [Related]
5. Increased levels of anti-oxidized low-density lipoprotein antibodies are associated with reduced levels of cholesterol in the general population.
Tinahones FJ; Gómez-Zumaquero JM; Rojo-Martínez G; Cardona F; Esteva de Antonio IE; Ruiz de Adana MS; Soriguer FJ
Metabolism; 2002 Apr; 51(4):429-31. PubMed ID: 11912548
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemia.
Boullier A; Hennuyer N; Tailleux A; Furman C; Duverger N; Caillaud JM; Castro G; Fievet C; Fruchart JC; Duriez P
Clin Sci (Lond); 2001 Mar; 100(3):343-55. PubMed ID: 11222122
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies against oxidatively modified low-density lipoprotein in patients with Behçet's disease.
Orem A; Cimşit G; Değer O; Vanizor B; Karahan SC
Dermatology; 1999; 198(3):243-6. PubMed ID: 10393445
[TBL] [Abstract][Full Text] [Related]
8. The significance of autoantibodies against oxidatively modified low-density lipoprotein (LDL) in patients with psoriasis.
Orem A; Cimşit G; Değer O; Orem C; Vanizor B
Clin Chim Acta; 1999 Jun; 284(1):81-8. PubMed ID: 10437645
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis.
Cvetkovic JT; Wållberg-Jonsson S; Ahmed E; Rantapää-Dahlqvist S; Lefvert AK
Rheumatology (Oxford); 2002 Sep; 41(9):988-95. PubMed ID: 12209031
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus.
Uusitupa MI; Niskanen L; Luoma J; Vilja P; Mercuri M; Rauramaa R; Ylä-Herttuala S
Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1236-42. PubMed ID: 8857919
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to oxidized low density lipoprotein: the relationship to low density lipoprotein fatty acid composition in diabetes.
Griffin ME; McInerney D; Fraser A; Johnson AH; Collins PB; Owens D; Tomkin GH
Diabet Med; 1997 Sep; 14(9):741-7. PubMed ID: 9300223
[TBL] [Abstract][Full Text] [Related]
12. Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk.
Maggi E; Finardi G; Poli M; Bollati P; Filipponi M; Stefano PL; Paolini G; Grossi A; Clot P; Albano E
Coron Artery Dis; 1993 Dec; 4(12):1119-22. PubMed ID: 8162245
[TBL] [Abstract][Full Text] [Related]
13. Changes of autoantibodies against oxidatively modified low density lipoproteins during long-term LDL-apheresis.
Turk Z; Mrzljak V; Turk N; Metelko Z
Diabetes Nutr Metab; 1999 Dec; 12(6):413-7. PubMed ID: 10782563
[TBL] [Abstract][Full Text] [Related]
14. Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery disease.
Boullier A; Hamon M; Walters-Laporte E; Martin-Nizart F; Mackereel R; Fruchart JC; Bertrand M; Duriez P
Clin Chim Acta; 1995 Jun; 238(1):1-10. PubMed ID: 7554289
[TBL] [Abstract][Full Text] [Related]
15. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL.
Heitzer T; Ylä-Herttuala S; Luoma J; Kurz S; Münzel T; Just H; Olschewski M; Drexler H
Circulation; 1996 Apr; 93(7):1346-53. PubMed ID: 8641023
[TBL] [Abstract][Full Text] [Related]
16. Oxidized low-density lipoprotein autoantibodies in patients with primary gout: effect of urate-lowering therapy.
Tsutsumi Z; Moriwaki Y; Takahashi S; Ka T; Yamamoto T
Clin Chim Acta; 2004 Jan; 339(1-2):117-22. PubMed ID: 14687901
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controls.
van de Vijver LP; Steyger R; van Poppel G; Boer JM; Kruijssen DA; Seidell JC; Princen HM
Atherosclerosis; 1996 May; 122(2):245-53. PubMed ID: 8769687
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies against oxidized low-density lipoprotein (ox-LDL) and LDL oxidation status.
Brizzi P; Tonolo G; Bertrand G; Carusillo F; Severino C; Maioli M; Malaguarnera L; Musumeci S
Clin Chem Lab Med; 2004 Feb; 42(2):164-70. PubMed ID: 15061355
[TBL] [Abstract][Full Text] [Related]
19. Increased autoantibodies against oxidized low-density lipoprotein in coronary circulation in patients with coronary spastic angina.
Ogawa H; Soejima H; Takazoe K; Miyamoto S; Kajiwara I; Shimomura H; Sakamoto T; Yoshimura M; Kugiyama K; Kimura M; Yasue H
Angiology; 2001 Mar; 52(3):167-74. PubMed ID: 11269779
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against oxidized LDL in chronic renal failure: role of renal function, diet, and lipids.
Bergesio F; Monzani G; Ciuti R; Cirami C; Martinelli F; Salvadori M; Tosi PL
Nephron; 2001 Feb; 87(2):127-33. PubMed ID: 11244306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
